Cargando…
Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung‐molGPA) in a Chinese cohort: A retrospective study of multiple institutions
BACKGROUND: In this era of precision medicine, prognostic heterogeneity is an important feature of patients with non‐small cell lung cancer (NSCLC) with brain metastases (BM). This multi‐institutional study is aimed to verify the applicability of the adjusted Lung‐molGPA model for NSCLC with BM in a...
Autores principales: | Zhang, Tingyou, Zhang, Yu, Zhou, Lin, Deng, Shanshan, Huang, Meijuan, Liu, Yuncong, Liu, Yongmei, Gong, Youlin, Zhu, Jiang, Xue, Jianxin, Bai, Yuju, Ma, Hu, Zhang, Yan, Yu, Min, Li, Yanying, Wang, Yongsheng, Zou, Bingwen, Zhou, Xiaojuan, Xiu, Weigang, Na, Feifei, Xu, Yong, Peng, Feng, Wang, Jin, Lu, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724493/ https://www.ncbi.nlm.nih.gov/pubmed/33027555 http://dx.doi.org/10.1002/cam4.3485 |
Ejemplares similares
-
Predictors of Lung Adenocarcinoma With Leptomeningeal Metastases: A 2022 Targeted-Therapy-Assisted molGPA Model
por: Zhang, Milan, et al.
Publicado: (2022) -
Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2017) -
Lung-molGPA Index Predicts Survival Outcomes of Non-Small-Cell Lung Cancer Patients with Synchronous or Metachronous Brain Metastases
por: Chen, Kaiyan, et al.
Publicado: (2020) -
Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
por: Nieder, Carsten, et al.
Publicado: (2018) -
Outcomes after stereotactic radiosurgery of brain metastases in patients with malignant melanoma and validation of the melanoma molGPA
por: Kessel, K. A., et al.
Publicado: (2021)